Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral microbiota and host oral mucosa represent a complex and dynamic biological system that serves as a critical interface between the host and the external environment (Dewhirst et al., 2010). This ecosystem consists of over 700 species of bacteria, along with fungi, viruses, and archaea, which colonize the various surfaces of the oral cavity, including the teeth and the mucosal epithelium (Lamont et al., 2018). Under healthy conditions, the host oral mucosa maintains a physical and immunological barrier while the commensal microbiota prevents the colonization of pathogens and aids in immune system maturation (Hajishengallis, 2015). However, a disruption in this symbiotic relationship, known as dysbiosis, is a primary driver of localized diseases such as periodontitis and dental caries, and has been increasingly linked to systemic conditions like cardiovascular disease and diabetes (NIDCR, 2023). Therapeutic strategies targeting this interface often involve broad-spectrum antimicrobials, probiotics, or biofilm disruptors designed to restore ecological balance rather than targeting a single molecular receptor (Marsh, 2010). Because this entry describes an entire biological environment rather than a specific protein or molecule, it is classified as a system-level target rather than a conventional therapeutic target.
Broad-spectrum antimicrobial activity, inhibition of bacterial cell wall synthesis, disruption of biofilm architecture, and competitive inhibition of pathogens by commensal species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral microbiota and host oral mucosa.